Montreal, Canada
NXTSENS is a Canadian-based startup with the slogan "Accuracy Matters." Launched in 2015, the company is a spin-off from McGill University, specializing in microtechnology. They have a strong focus on the manufacturing and semiconductor industries. NXTSENS has developed two key technologies, MY01 and Stathera, with MY01 being a state-of-the-art medical diagnostic aid for acute compartment syndrome and Stathera delivering tailored timing and frequency reference solutions for the semiconductor industry.
Of note, MY01 was recognized as one of the top 50 Medtech's by Medtech Innovator (2018), showcasing the company's potential impact in the medical technology sector. Furthermore, Stathera gained attention by being the only Canadian company to be included in the EE Times Silicon 60: 2018’s Emerging Companies to Watch.
The last investment NXTSENS received was a grant investment on 01 May 2017, with MedTech Innovator being the investor. This support reflects the industry's recognition of NXTSENS' potential and the value of their innovative technologies.
